Amgen (AMGN) Eliminating Up To 2,900 Jobs, Will Shutter Seattle, Bothell Sites
Rumor: Sarepta Therapeutics (SRPT) Chairman Moves To Keep CEO Out Of FDA Meetings
AstraZeneca PLC (AZN) Scoops Up Almirall Lung Drugs For Up To $2.1 Billion
Pfizer Inc. (PFE) Grabs Baxter International, Inc. (BAX)'s Portfolio Of Marketed Vaccines For $635 Million
Regeneron Pharmaceuticals, Inc. (REGN), Sanofi (France) (SAN.PA) Drug Alirocumab Cuts Cholesterol In Nine Late-Stage Trials
Incyte Corporation (INCY) Partners With Genentech (RHHBY) To Help With Cancer Immunotherapy Trials
IMPAX Laboratories, Inc. (IPXL) Parkinson's Drug Future Shaky As FDA Cites Factory Issues
Pfizer Inc. (PFE) CEO Aggressively Seeking Deals, Leaves Investors Guessing On AstraZeneca PLC (AZN) Intentions
Merck & Co., Inc. (MRK): No Tax Inversions, We Just Want Bolt-On Deals
Leidos Awarded $44 Million Contract By The Centers for Disease Control and Prevention (CDC)
TherapeuticsMD, Inc.  (TXMD) Announces $40 Million Offering Of Common Stock
Second Failure Of The Month As Targacept, Inc. (TRGT) Halts Development Of Bladder Drug, Shares Plunge
Big Pharmas Such As Eli Lilly and Company (LLY), Johnson & Johnson (JNJ), Pfizer Inc. (PFE) Pitch In On $51.1 Million Fund For New York City And Seattle Biotechs
Sanofi Pasteur (SASY.PA) Abandons Antibiotics Deal With South San Francisco's KaloBios Pharmaceuticals, Inc. (KBIO)
New York Biotech ContraFect Corporation (CFRXU) Prices Upsized IPO At $5-6 A Share
Pfizer Inc. (PFE)'s Need For A Deal Looms Larger As Second Quarter Profits Sinks 79 Percent
Four Biotech-Related Companies Sign Up For Start-Up NY Program, New Jobs Created
Merck & Co., Inc. (MRK) Second Quarter Profit More Than Doubles As Newer Drugs Offset Generics
See All News >
Allergan Inc. (AGN) Layoffs: Employees Tell Their Side Of The Story
GlaxoSmithKline (GSK) May Separate Businesses
Why Men Like Nice Women And Why Women Like Bad Boys, University of Rochester Study
FDA Rejects Redwood City's AcelRx Pharmaceuticals (ACRX) Painkiller Dispensing Device; Stock Plunges -34.35% At 9:37AM ET
Novartis AG (NVS) Layoffs: Game-Changing Tips For Today’s Job Seeker
Bristol-Myers Squibb Company (BMY) Taps Bay Area's Redwood City For Expansion, Pharma Giant To Increase Workforce
Bay Area's PaxVax, Inc. Reels In Up To $60 Million Financing
3 Future Biotech Blockbusters To Watch?
Politicizing Gilead Sciences, Inc. (GILD)'s R&D Solvadi Costs Is A Reckless And Dangerous Misadventure
Zealand Pharma  (ZEAL.CO), Boehringer Ingelheim Corporation Strike $402 Million Peptide Pact
FDA Approves Purdue Pharma L.P.’s Hard-to-Abuse Narcotic Painkiller
U.S. FDA Grants Regular (Full) Approval For Pharmacyclics, Inc. (PCYC)'s IMBRUVICA® For Two Indications
Clinuvel Snags A $95 Million Takeover Bid From New York-Based Retrophin, Inc. (RTRX)
Slow Walking Speed And Memory Issues Linked To Early Signs Of Dementia, Albert Einstein College of Medicine Study
Layoffs Make Allergan Inc. (AGN), Microsoft CEOs Look Like Heroes—And That's Why Corporate America Is Sick
Google Inc.'s Next Project: The Human Body
Amgen (AMGN) Nervous As FDA Paves Way For Novartis AG (NVS) To Copy Drug Neupogen
Management Reshuffle At Ranbaxy Laboratories (RANBAXY.BO): Arno Gessner Promoted, New R&D Head Named
See All News >
//-->